Tariquidar (XR9576)

Catalog No. A11584

Tariquidar (XR9576)是一种P-糖蛋白药物外排泵抑制剂。
  • Yuko Sasaki, .et al. Intestinal Permeability of Drugs in Caco-2 Cells Cultured in Microfluidic Devices, Biol Pharm Bull, 2022, 45(9):1246-1253 PMID: 36047192
  • Sugisawa N, .et al. Novel Potent ABCB1 Modulator, Phenethylisoquinoline Alkaloid, Reverses Multidrug Resistance in Cancer Cell, Mol Pharm, 2018, Sep 4;15(9):4021-4030 PMID: 30052463
  • Samy A. F. Morad, .et al. Role of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancer, Biochem Pharmacol, 2017, Apr 15; 130: 21-33 PMID: 28189725
  • Debora Petroni, .et al. Synthesis and In Vivo Imaging of N-(3-[11C]Methoxybenzyl)-2-(3-Methoxyphenyl)ethylaniline as a Potential Targeting Agent for P-glycoprotein, Mol Imaging Biol, 2016, Dec;18(6):916-923 PMID: 27234445
Catalog Num A11584
M. Wt 646.73
Formula C38H38N4O6
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 206873-63-4
Synonyms XR 9576??XR9576??D06008
SMILES COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)NC(=O)C4=CC(=C(C=C4NC(=O)C5=CC6=CC=CC=C6N=C5)OC)OC)OC
Tariquidar (XR9576)是一种P-糖蛋白药物外排泵抑制剂。
Targets
P-gp (CHrB30 cells)
5.1 nM(Kd)
In vitro DMSO 48 mg/mL (74.22 mM)
Water Insoluble
Ethanol Insoluble
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 15.46 mL 77.31 mL 154.62 mL
0.5 mM 3.09 mL 15.46 mL 30.92 mL
1 mM 1.55 mL 7.73 mL 15.46 mL
5 mM 0.31 mL 1.55 mL 3.09 mL

*The above data is based on the productmolecular weight 646.73. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.